Guardant Health
GH
#1125
Rank
โ‚ฌ18.76 B
Marketcap
139,80ย โ‚ฌ
Share price
2.01%
Change (1 day)
178.12%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -2,89ย โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -2,90ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,83ย โ‚ฌ an increase over its 2024 EPS that were of -3,05ย โ‚ฌ.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,89ย โ‚ฌ2.18%
2025-2,83ย โ‚ฌ-7.02%
2024-3,05ย โ‚ฌ-16.82%
2023-3,66ย โ‚ฌ-33.13%
2022-5,48ย โ‚ฌ60%
2021-3,42ย โ‚ฌ55.04%
2020-2,21ย โ‚ฌ207.14%
2019-0,72ย โ‚ฌ-19.81%
2018-0,90ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-2,40ย โ‚ฌ-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-2,12ย โ‚ฌ-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA